Plagiarism Screening Policy | Medicomplementary Journal

About Journal

Medicomplementary Journal e-ISSN: 2808-3342, is a peer-reviewed, open-access research journal that publishes high-quality, original studies in engineering, agriculture, health sciences, and pharmacy. The journal provides a platform for fundamental research, novel theoretical developments, applied innovations, and comprehensive reviews, with an emphasis on rigor, originality, and interdisciplinary relevance. Published twice a year (February and August), the journal is committed to advancing scientific knowledge and fostering scholarly collaboration at both national and international levels.

Medicomplementary Journal upholds strict academic integrity standards and does not tolerate plagiarism in any form. All submitted manuscripts are screened for plagiarism using reputable plagiarism detection software (e.g., Turnitin, iThenticate, or similar tools) prior to the peer-review process.

The maximum allowable similarity index is 20% (excluding references, quotations, and standard methodology descriptions).
Manuscripts exceeding this threshold will be returned to the authors for revision or rejected outright at the discretion of the editorial board.
Any evidence of plagiarism, including self-plagiarism, duplicate publication, or fabricated content, will be handled according to the Committee on Publication Ethics (COPE) guidelines.
Authors are encouraged to carefully review and edit their manuscripts to ensure originality before submission.

By enforcing this policy, Medicomplementary Journal seeks to maintain high ethical standards, safeguard intellectual property, and promote a culture of responsible and credible scientific publishing.